A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

For Oak Cliff native Katherine Craft, the new audio comedy series Shaky is personal. The writer-director’s nine-episode ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...